Login
Home
Charts
Search
Watchlist
Products

Advance Agrolife Ltd

ADVANCE·NSE
108.14+0.29%Tue, 22 Sept '26

Advance Agrolife Ltd

ADVANCE
NSE
108.14
+0.29%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
692Cr
Close
Close Price
107.72
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
12.60
PS
Price To Sales
0.87
Revenue
Revenue
800Cr
Rev Gr TTM
Revenue Growth TTM
48.33%
PAT Gr TTM
PAT Growth TTM
78.66%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
13216711390169213133124330
Growth YoY
Revenue Growth YoY%
27.927.017.237.995.9
Expenses
ExpensesCr
11914410784152187125111295
Operating Profit
Operating ProfitCr
122366172671335
OPM
OPM%
9.513.75.66.510.212.15.510.810.6
Other Income
Other IncomeCr
000000120
Interest Expense
Interest ExpenseCr
111222122
Depreciation
DepreciationCr
222223333
PBT
PBTCr
102032132141030
Tax
TaxCr
361145138
PAT
PATCr
714319163723
Growth YoY
PAT Growth YoY%
23.811.78.3421.7152.2
NPM
NPM%
5.58.52.51.65.37.52.36.06.8
EPS
EPS
1.63.20.60.32.03.50.51.13.5
QuarterJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
13216711390169213133124330
Growth YoY
Revenue Growth YoY%
27.927.017.237.995.9
Expenses
ExpensesCr
11914410784152187125111295
Operating Profit
Operating ProfitCr
122366172671335
OPM
OPM%
9.513.75.66.510.212.15.510.810.6
Other Income
Other IncomeCr
000000120
Interest Expense
Interest ExpenseCr
111222122
Depreciation
DepreciationCr
222223333
PBT
PBTCr
102032132141030
Tax
TaxCr
361145138
PAT
PATCr
714319163723
Growth YoY
PAT Growth YoY%
23.811.78.3421.7152.2
NPM
NPM%
5.58.52.51.65.37.52.36.06.8
EPS
EPS
1.63.20.60.32.03.50.51.13.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
206251398456502638800
Growth
Revenue Growth%
22.058.614.610.227.048.3
Expenses
ExpensesCr
190237373417455574718
Operating Profit
Operating ProfitCr
16142539486482
OPM
OPM%
7.65.66.38.59.510.010.2
Other Income
Other IncomeCr
0201144
Interest Expense
Interest ExpenseCr
1234598
Depreciation
DepreciationCr
222381111
PBT
PBTCr
12122033354866
Tax
TaxCr
3359101317
PAT
PATCr
991525263549
Growth
PAT Growth%
-0.665.466.33.737.678.7
NPM
NPM%
4.43.63.75.45.15.56.1
EPS
EPS
20.12.03.35.65.76.58.6
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
206251398456502638800
Growth
Revenue Growth%
22.058.614.610.227.048.3
Expenses
ExpensesCr
190237373417455574718
Operating Profit
Operating ProfitCr
16142539486482
OPM
OPM%
7.65.66.38.59.510.010.2
Other Income
Other IncomeCr
0201144
Interest Expense
Interest ExpenseCr
1234598
Depreciation
DepreciationCr
222381111
PBT
PBTCr
12122033354866
Tax
TaxCr
3359101317
PAT
PATCr
991525263549
Growth
PAT Growth%
-0.665.466.33.737.678.7
NPM
NPM%
4.43.63.75.45.15.56.1
EPS
EPS
20.12.03.35.65.76.58.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
55554564
Reserves
ReservesCr
2231467156246
Current Liabilities
Current LiabilitiesCr
5279123170235296
Non Current Liabilities
Non Current LiabilitiesCr
746141619
Total Liabilities
Total LiabilitiesCr
86119179260351625
Current Assets
Current AssetsCr
70101156208272494
Non Current Assets
Non Current AssetsCr
1618245279131
Total Assets
Total AssetsCr
86119179260351625
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
55554564
Reserves
ReservesCr
2231467156246
Current Liabilities
Current LiabilitiesCr
5279123170235296
Non Current Liabilities
Non Current LiabilitiesCr
746141619
Total Liabilities
Total LiabilitiesCr
86119179260351625
Current Assets
Current AssetsCr
70101156208272494
Non Current Assets
Non Current AssetsCr
1618245279131
Total Assets
Total AssetsCr
86119179260351625

Cash Flow

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
806156-70
Investing Cash Flow
Investing Cash FlowCr
-6-3-8-31-34-108
Financing Cash Flow
Financing Cash FlowCr
-2411728183
Net Cash Flow
Net Cash FlowCr
000005
Free Cash Flow
Free Cash FlowCr
2-3-2-15-27-109
CFO To PAT
CFO To PAT%
87.8-1.541.560.022.3-198.5
CFO To EBITDA
CFO To EBITDA%
51.1-1.024.638.112.0-110.0
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
806156-70
Investing Cash Flow
Investing Cash FlowCr
-6-3-8-31-34-108
Financing Cash Flow
Financing Cash FlowCr
-2411728183
Net Cash Flow
Net Cash FlowCr
000005
Free Cash Flow
Free Cash FlowCr
2-3-2-15-27-109
CFO To PAT
CFO To PAT%
87.8-1.541.560.022.3-198.5
CFO To EBITDA
CFO To EBITDA%
51.1-1.024.638.112.0-110.0

Ratios

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
547692
Price To Earnings
Price To Earnings
15.512.6
Price To Sales
Price To Sales
0.90.9
Price To Book
Price To Book
1.82.2
EV To EBITDA
EV To EBITDA
8.99.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
17.312.512.916.217.617.017.0
OPM
OPM%
7.65.66.38.59.510.010.2
NPM
NPM%
4.43.63.75.45.15.56.1
ROCE
ROCE%
32.224.730.030.522.413.913.9
ROE
ROE%
33.625.229.432.925.411.411.4
ROA
ROA%
10.57.68.39.57.35.75.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
547692
Price To Earnings
Price To Earnings
15.512.6
Price To Sales
Price To Sales
0.90.9
Price To Book
Price To Book
1.82.2
EV To EBITDA
EV To EBITDA
8.99.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
17.312.512.916.217.617.017.0
OPM
OPM%
7.65.66.38.59.510.010.2
NPM
NPM%
4.43.63.75.45.15.56.1
ROCE
ROCE%
32.224.730.030.522.413.913.9
ROE
ROE%
33.625.229.432.925.411.411.4
ROA
ROA%
10.57.68.39.57.35.75.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Advance Agrolife Ltd is a pure manufacturer - it does not sell to farmers, advertise brands, or chase retail shelf space. Over two decades it has moved from trading micro-nutrients to running three integrated factories that make the active chemicals and finished crop-protection products that India’s largest fertiliser and agri-input companies put in their own bottles and bags. The recurring approach is to own the molecule, not the brand: invest in hard manufacturing assets, lock in large B2B customers through regulatory approvals tied to its plants, and locate production where freight costs give it a permanent cost advantage over rivals. # Business segments A single integrated engine - agrochemical manufacturing - where the company makes both the active ingredient and the finished formulation, then sells exclusively to other businesses under their labels. ## 1. Agrochemical manufacturing: the industry’s factory floor **The company makes the molecules and the ready-to-use crop-protection products that large fertiliser and agri-input companies sell under their own brands - it is a behind-the-scenes manufacturer, not a marketer.** - **Backward-integrated into the active ingredient** - since 2024, the company has produced its own technical-grade chemicals (the biologically active part of a pesticide) at Unit I, rather than buying them from China or elsewhere; that lets it capture the full margin between raw material and finished product and target a 25-30% reduction in cost of goods sold on specific products. - **Three plants, three jobs** - Unit I (6,900 MT capacity) is the technical hub making herbicides, fungicides and intermediates for captive use; Unit II (51,000 MT) is a dedicated sulphur-formulation plant, ranked among the largest of its kind globally, focused on high-margin sulphur and tebuconazole blends; Unit III (32,000 MT) is the high-volume liquid-insecticide, herbicide and bio-fertiliser line built for speed and large B2B contracts. - **The sulphur niche is a sticky revenue stream** - Unit II produces specialised formulations like Sulphur 80% WDG (water-dispersible granules) and WP (wettable powder), which are harder to make than standard liquids and command better margins; the plant has been dedicated to this chemistry since 2017. - **A portfolio balanced across seasons** - the product range spans insecticides, herbicides, fungicides, plant growth regulators and bio-fertilisers, split between the Kharif (monsoon) and Rabi (winter) cropping cycles so that demand does not collapse in any single quarter. - **Technical feeds formulation directly** - Unit I’s output moves straight into the downstream formulation lines without intermediate packaging or road transport, cutting handling costs and time. ## 2. B2B supply partnerships: embedded in the customer’s factory **The company’s manufacturing site is written into its customers’ product licences - switching supplier means re-filing with the regulator, which makes the relationship extremely hard to break.** - **Registrations are the moat** - the company holds over 410 product registrations (380 formulations and 30 technicals) with India’s Central Insecticides Board; when a large customer approves a product made at AAL’s site, any change of supplier requires fresh stability testing and regulatory re-filing, a costly and slow process that locks the business in. - **Top-tier customers, concentrated revenue** - the client list includes DCM Shriram, NFL, Zuari Ind, IFFCO, Coromandel, Mankind Agritech, HPM, Indogulf, Chambal Fertilisers and Matrix Fertiliser; the top 10 customers account for roughly 69% of revenue, and several have been with the company for more than three years. - **Zero marketing, zero brand risk** - because AAL is a pure B2B manufacturer, it spends nothing on advertising or farmer-facing promotion and carries minimal credit risk; its customers are large, established corporates that take the branded product to market themselves. - **The registration library as a shock absorber** - when a molecule is banned or phased out, the company can immediately substitute an approved alternative from its existing library, keeping its customers’ supply lines running without a regulatory gap. ## 3. Geographic advantage: a freight moat in the desert **By building its factories in Jaipur, Rajasthan, the company sits next door to the states that consume over a third of India’s agrochemicals - saving on transport and winning on speed.** - **Proximity to the demand belt** - Punjab, Haryana, Madhya Pradesh and Uttar Pradesh together consume about 35% of the country’s crop-protection chemicals; AAL’s Jaipur plants are a short haul from these markets, while coastal competitors face long, expensive freight journeys that erode their margins. - **24-hour delivery during pest outbreaks** - when a sudden pest attack triggers panic buying, the company can deliver product within a day; competitors shipping from coastal locations typically need seven days, by which time the buying window may have closed. - **Export reach as a secondary leg** - the domestic network covers 19 states and 2 Union Territories, while exports go to seven countries - UAE, Bangladesh, China, Turkey, Egypt, Kenya and Nepal - providing a diversification channel without distracting from the core B2B domestic model. ## 4. Backward-integration pipeline: building the next molecule **The company is using anti-dumping duties on Chinese imports as a pricing umbrella to bring new active-ingredient production in-house, starting with a herbicide for India’s biggest crop.** - **Quadrupling 2,4-D herbicide capacity** - a 4x expansion from 2,500 MT to 10,000 MT is planned by Q4 FY28 to fill a structural supply gap in the domestic market; the company is evaluating a site in the Dahej PCPIR (Petroleum, Chemicals and Petrochemicals Investment Region) in Gujarat, where key inputs like phenol and chlorine could arrive by pipeline and finished goods could ship directly from the port for global exports. - **Two more factories on the drawing board** - a new Unit-4 technical facility is planned at Gidhani with first-phase capital expenditure of roughly ₹250 million, and land has been secured via an MOU for a Unit-5 at Dahej II GIDC Industrial Estate in Bharuch, Gujarat, for manufacturing technical-grade pesticides. - **A small renewable-energy step** - a 3.75 MW solar power plant is being set up to increase the share of renewable energy in the company’s manufacturing operations.

Documents — Advance Agrolife Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/bqkykaxk8hzw9f2iqelolwe8.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/qknpd4phyr7cs5qpyvbm3hbk.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/64l059qq6nptk3g5710wi2di.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/9c3nghxf1exr0tww6z0da53j.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/6u49eex0iowxosqrys5rfekp.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/w2qkdr5r3h777t8xnvm5pzc9.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/5968bx8skno05agx2pzkkrsx.pdf